Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
Q.2 (Alpha)NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
BL.1.1ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
BL.1.1ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
BL.1.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BL.1.1NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
M.3ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
M.3ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
M.3ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
M.3NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
C.2ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
C.2ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
C.2ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
C.2NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
AY.82 (Delta)ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
AY.82 (Delta)ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
AY.82 (Delta)ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
AY.82 (Delta)NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
A.30ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
A.30ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
A.30ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
A.30NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-17121.6US
B.1.36.35ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
B.1.36.35ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.36.35ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.36.35NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-17890.7US
AY.23.1 (Delta)ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
AY.23.1 (Delta)ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
AY.23.1 (Delta)ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
AY.23.1 (Delta)NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
B.1.466.1ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
B.1.466.1ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.466.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.466.1NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
B.1.213ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
BA.2.75.9ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
BA.2.75.9ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
BA.2.75.9ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BA.2.75.9NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
XBHORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
XBHENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
XBHENiu-ECACGTTAACAATATTGCAGC20402639126372R-3181.36China
XBHNUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
BL.1.2ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
BL.1.2ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
BL.1.2ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BL.1.2NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
BQ.1.1.78ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
BQ.1.1.78ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
BQ.1.1.78ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BQ.1.1.78NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used